Back to top

Opening Day: Scribe Therapeutics makes strong trading debut

Scribe Therapeutics makes its public debut above issue price as the CRISPR drug developer opened for trading last week. The biotech entered the mar...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Genpact Limited (G)

Jones Energy, Inc. (JONE)